BIRC5 and ovarian carcinoma: BIRC5 expression is significantly higher in cancer tissue than in normal tissue in 16 different cancer types 22, and several studies have implicated BIRC5 in chemoresistance to platinum- or taxane-based chemotherapy in ovarian cancer 23, 24.